 Evogene Ltd. NASDAQ: EVGN TASE: EVGN, a leading company in leveraging computational biology to design novel products for life-science-based industries including: human health, agriculture and industrial applications, announces today that it will release its financial results for the fourth quarter and full year of 2019 on Wednesday, March 4, 2020. 